Literature DB >> 25105300

Regulation of autophagy by α1-antitrypsin: "a foe of a foe is a friend".

Michal G Shapira1, Boris Khalfin2, Eli C Lewis3, Abraham H Parola4, Ilana Nathan5.   

Abstract

Autophagy is involved in both the cell protective and the cell death process but its mechanism is largely unknown. The present work unravels a novel intracellular mechanism by which the serpin α1-antitrypsin (AAT) acts as a novel negative regulator of autophagic cell death. For the first time, the role of intracellularly synthesized AAT, other than in liver cells, is demonstrated. Autophagic cell death was induced by N-α-tosyl-L-phenylalanine chloromethyl ketone (TPCK) and tamoxifen. By utilizing a fluorescently tagged TPCK analog, AAT was "fished out" (pulled out) as a TPCK intracellular protein target. The interaction was further verified by competition binding experiments. Both inducers caused downregulation of AAT expression associated with activation of trypsin-like proteases. Furthermore, silencing AAT by siRNA induced autophagic cell death. Moreover, AAT administration to cultured cells prevented autophagic cell death. This new mechanism could have implications in the treatment of diseases by the regulation of AAT levels in which autophagy has a detrimental function. Furthermore, the results imply that the high synthesis of endogenous AAT by cancer cells could provide a novel resistance mechanism of cancer against autophagic cell death.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25105300      PMCID: PMC4212011          DOI: 10.2119/molmed.2014.00054

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  39 in total

Review 1.  The end of the (cell) line: methods for the study of apoptosis in vitro.

Authors:  A J McGahon; S J Martin; R P Bissonnette; A Mahboubi; Y Shi; R J Mogil; W K Nishioka; D R Green
Journal:  Methods Cell Biol       Date:  1995       Impact factor: 1.441

Review 2.  Autophagy as a therapeutic target in cancer.

Authors:  Ning Chen; Vassiliki Karantza
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

3.  Human cationic and anionic trypsins: differences of interaction with alpha 1-proteinase inhibitor.

Authors:  D Vercaigne-Marko; J Carrère; O Guy-Crotte; C Figarella; A Hayem
Journal:  Biol Chem Hoppe Seyler       Date:  1989-11

Review 4.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

5.  alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis.

Authors:  Irina Petrache; Iwona Fijalkowska; Terry R Medler; Jarrett Skirball; Pedro Cruz; Lijie Zhen; Horia I Petrache; Terence R Flotte; Rubin M Tuder
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.

Authors:  Y Huang; M S Sheikh; A J Fornace; N J Holbrook
Journal:  Oncogene       Date:  1999-06-10       Impact factor: 9.867

7.  Alpha1-antitrypsin inhibits angiogenesis and tumor growth.

Authors:  Hanhua Huang; Steven C Campbell; Thomas Nelius; Dhugal F Bedford; Dorina Veliceasa; Noel P Bouck; Olga V Volpert
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

8.  Alpha1-antitrypsin protects beta-cells from apoptosis.

Authors:  Bin Zhang; Yuanqing Lu; Martha Campbell-Thompson; Terry Spencer; Clive Wasserfall; Mark Atkinson; Sihong Song
Journal:  Diabetes       Date:  2007-03-14       Impact factor: 9.461

9.  A starvation-specific serine protease gene, isp6+, is involved in both autophagy and sexual development in Schizosaccharomyces pombe.

Authors:  Akio Nakashima; Takahiro Hasegawa; Saori Mori; Masaru Ueno; Shigeyasu Tanaka; Takashi Ushimaru; Shusei Sato; Masahiro Uritani
Journal:  Curr Genet       Date:  2006-03-21       Impact factor: 2.695

10.  An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; R Tateishi
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more
  2 in total

1.  Humanin Derivatives Inhibit Necrotic Cell Death in Neurons.

Authors:  Aviv Cohen; Jenny Lerner-Yardeni; David Meridor; Roni Kasher; Ilana Nathan; Abraham H Parola
Journal:  Mol Med       Date:  2015-06-04       Impact factor: 6.354

2.  Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.

Authors:  Yongfeng Wang; Kaili Lin; Tianchun Xu; Liuli Wang; Liangyin Fu; Guangming Zhang; Jing Ai; Yajun Jiao; Rongrong Zhu; Xiaoyong Han; Hui Cai
Journal:  Aging (Albany NY)       Date:  2021-07-27       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.